GlaxoSmithKline Pharmaceuticals
| Държава: | Германия |
| Кратка информация: | In communities around the world, people affected by certain diseases face stigma and discrimination, disability and a vicious cycle of ill health and poverty. In the developing world, diseases that can be prevented, managed or cured cause significant suffering and mortality due to a lack of basic knowledge and inadequate health services. We support activities to tackle these diseases through donations of medicines, financial and practical support. We have chosen to focus our efforts on lymphatic filariasis (LF) and malaria as well as diarrhoea-related disease in children. Lymphatic Filariasis Also known as elephantiasis or LF, this is a disfiguring disease found mainly in tropical countries. It is caused by a parasite and spread by mosquitoes. It is one of the world's major causes of permanent disability affecting over 120 million people. We are a key member of the Global Alliance to Eliminate Lymphatic Filariasis, a 20 year programme to eliminate the disease by donating our anti-parasitic medicine albendazole. Malaria Malaria is a mosquito-borne parasitic disease that kills nearly 800,000 people a year. Over 90 per cent of all malaria deaths occur in Africa where it remains a leading cause of childhood mortality. GSK’s African Malaria Partnership (AMP) was established in 2001 to improve prevention and treatment of malaria in sub-Saharan Africa. Since then we have committed over £3 million on malaria initiatives. In late 2009, the AMP announced new partnerships in Ghana, Nigeria, Kenya, and Tanzania to strengthen community-based efforts to fight malaria. These projects focus on building capacity for community health workers and creating behaviour change. Personal Hygiene and Sanitation Education (PHASE) Every year more than three million people die of diarrhoea-related disease, mostly children in developing countries. These deaths can often be easily prevented through better hand washing and sanitation. Established in 1988, PHASE is a low-cost education programme helping to reduce diarrhoea-related disease by encouraging school children to wash their hands. PHASE currently operates in 16 countries – Bangladesh, Bolivia, Brazil, India, Indonesia, Kenya, Malawi, Mexico, Nicaragua, Peru, Philippines, Senegal, Tajikistan, Uganda, UK and Zambia- reaching more than one million children and their extended families. Intestinal worms Intestinal worms infect hundreds of millions of children around the world. The three most common intestinal parasites – hookworms, whipworms and roundworms – cause infections that are chronic and widespread, often resulting in malnutrition and impaired cognitive and physical development. We have made a five year commitment to help de-worm school age children through a donation of up to 400 million albendazole treatments each year. |
| Сайт: | http://gsk.com |
Търсене в сайта
Лекарствен справочник
http://sommons.co/out?zoneId=2647810-2647961 Банер II
